The FINANCIAL — Allergan plc, on June 1 announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVÉDERM VOLBELLA XC, for use in the lips for lip ...
Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, today announced that the company has received approval from the U.S. Food and Drug Administration (FDA) to market JUVEDERM ® ULTRA ...
The U.S. Food and Drug Administration today approved Allergan PLC’s Juvéderm Ultra XC for lip augmentation in adults who are at least 21 years old. Allergan’s facial aesthetic and eye drug hubs are ...
It’s all about the lips in Allergan’s latest Juvederm campaign. In its first consumer effort focused on lip treatments, Allergan looks to especially target millennials with a natural—but ...
Hyaluronic acid 15mg/mL, 0.3% w/w lidocaine; injectable gel implant. Should only be used by trained and experienced healthcare practitioners. Obtain patient's complete medical history prior to ...
IRVINE, Calif., Aug. 1, 2023 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the first ever JUVÉDERM® Day on Wednesday, August 16, 2023. The celebration recognizes the ...
Juvéderm and Restylane are two types of dermal fillers used for the treatment of wrinkles. Both injections use a gel made with hyaluronic acid to plump up the skin. These are noninvasive procedures.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results